David H. Raulet - Publications

Affiliations: 
1991 Biology Massachusetts Institute of Technology, Cambridge, MA, United States 
 1991- University of California, Berkeley, Berkeley, CA 

200 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Marcus A, Mao AJ, Lensink-Vasan M, Wang L, Vance RE, Raulet DH. Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. Immunity. 49: 754-763.e4. PMID 30332631 DOI: 10.1016/j.immuni.2018.09.016  1
2018 Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault MC, Trevino TN, Azimi CS, Scheer AK, Randolph HE, Thompson TW, Zhang L, Iannello A, Mathur N, Jardine KE, Kirn GA, ... ... Raulet DH, et al. Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. The Journal of Clinical Investigation. PMID 30198904 DOI: 10.1172/JCI99317  0.64
2017 Raulet DH, Marcus A, Coscoy L. Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells. Immunological Reviews. 280: 93-101. PMID 29027233 DOI: 10.1111/imr.12600  0.56
2017 Vance RE, Eichberg MJ, Portnoy DA, Raulet DH. Listening to each other: Infectious disease and cancer immunology. Science Immunology. 2. PMID 28783669 DOI: 10.1126/sciimmunol.aai9339  1
2016 Bose D, Su Y, Marcus A, Raulet DH, Hammond MC. An RNA-Based Fluorescent Biosensor for High-Throughput Analysis of the cGAS-cGAMP-STING Pathway. Cell Chemical Biology. PMID 27889408 DOI: 10.1016/j.chembiol.2016.10.014  0.56
2016 Tovbis Shifrin N, Kissiov DU, Ardolino M, Joncker NT, Raulet DH. Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness. Journal of Immunology (Baltimore, Md. : 1950). PMID 27798146 DOI: 10.4049/jimmunol.1402447  0.64
2016 Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, Chen MB, Krall JA, DeCock J, Zervantonakis IK, Iannello A, Iwamoto Y, Cortez-Retamozo V, Kamm RD, Pittet MJ, ... Raulet DH, et al. Neutrophils suppress intraluminal NK-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discovery. PMID 27072748 DOI: 10.1158/2159-8290.CD-15-1157  0.64
2016 Ardolino M, Raulet DH. Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumors. Oncoimmunology. 5: e1002725. PMID 26942049 DOI: 10.1080/2162402X.2014.1002725  1
2015 Iannello A, Thompson TW, Ardolino M, Marcus A, Raulet DH. Immunosurveillance and immunotherapy of tumors by innate immune cells. Current Opinion in Immunology. 38: 52-58. PMID 26686774 DOI: 10.1016/j.coi.2015.11.001  1
2015 Gowen BG, Chim B, Marceau CD, Greene TT, Burr P, Gonzalez JR, Hesser CR, Dietzen PA, Russell T, Iannello A, Coscoy L, Sentman CL, Carette JE, Muljo SA, Raulet DH. A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells. Elife. 4. PMID 26565589 DOI: 10.7554/eLife.08474  1
2015 Raulet DH. Bone Marrow Cell Rejection, MHC, NK Cells, and Missing Self Recognition: Ain't That Peculiar (with Apologies to Marvin Gaye). Journal of Immunology (Baltimore, Md. : 1950). 195: 2923-5. PMID 26386035 DOI: 10.4049/jimmunol.1501804  1
2015 Ardolino M, Hsu J, Raulet DH. Cytokine treatment in cancer immunotherapy. Oncotarget. 6: 19346-7. PMID 26305981  0.64
2015 Karimi MA, Bryson JL, Richman LP, Fesnak AD, Leichner TM, Satake A, Vonderheide RH, Raulet DH, Reshef R, Kambayashi T. NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT. Blood. 125: 3655-63. PMID 25788701 DOI: 10.1182/blood-2015-02-629006  1
2015 Deng W, Gowen BG, Zhang L, Wang L, Lau S, Iannello A, Xu J, Rovis TL, Xiong N, Raulet DH. Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection. Science (New York, N.Y.). 348: 136-9. PMID 25745066 DOI: 10.1126/science.1258867  1
2015 Ardolino M, Hsu J, Raulet DH. Cytokine treatment in cancer immunotherapy Oncotarget. 6: 19346-19347.  1
2014 Ardolino M, Azimi CS, Iannello A, Trevino TN, Horan L, Zhang L, Deng W, Ring AM, Fischer S, Garcia KC, Raulet DH. Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. The Journal of Clinical Investigation. 124: 4781-94. PMID 25329698 DOI: 10.1172/JCI74337  1
2014 Iannello A, Raulet DH. Immunosurveillance of senescent cancer cells by natural killer cells. Oncoimmunology. 3: e27616. PMID 24800169 DOI: 10.4161/onci.27616  1
2014 Shifrin N, Raulet DH, Ardolino M. NK cell self tolerance, responsiveness and missing self recognition. Seminars in Immunology. 26: 138-44. PMID 24629893 DOI: 10.1016/j.smim.2014.02.007  1
2014 Lam AR, Le Bert N, Ho SS, Shen YJ, Tang ML, Xiong GM, Croxford JL, Koo CX, Ishii KJ, Akira S, Raulet DH, Gasser S. RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma. Cancer Research. 74: 2193-203. PMID 24590060 DOI: 10.1158/0008-5472.CAN-13-1703  1
2014 Marcus A, Gowen BG, Thompson TW, Iannello A, Ardolino M, Deng W, Wang L, Shifrin N, Raulet DH. Recognition of tumors by the innate immune system and natural killer cells. Advances in Immunology. 122: 91-128. PMID 24507156 DOI: 10.1016/B978-0-12-800267-4.00003-1  1
2013 Guerra N, Pestal K, Juarez T, Beck J, Tkach K, Wang L, Raulet DH. A selective role of NKG2D in inflammatory and autoimmune diseases. Clinical Immunology (Orlando, Fla.). 149: 432-9. PMID 24211717 DOI: 10.1016/j.clim.2013.09.003  1
2013 Iannello A, Raulet DH. Immune surveillance of unhealthy cells by natural killer cells. Cold Spring Harbor Symposia On Quantitative Biology. 78: 249-57. PMID 24135717 DOI: 10.1101/sqb.2013.78.020255  1
2013 Iannello A, Thompson TW, Ardolino M, Lowe SW, Raulet DH. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. The Journal of Experimental Medicine. 210: 2057-69. PMID 24043758 DOI: 10.1084/jem.20130783  1
2013 Marcus A, Raulet DH. Evidence for natural killer cell memory. Current Biology : Cb. 23: R817-20. PMID 24028966 DOI: 10.1016/j.cub.2013.07.015  1
2013 Marcus A, Raulet DH. A simple and effective method for differentiating GFP and YFP by flow cytometry using the violet laser. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 83: 973-4. PMID 24022832 DOI: 10.1002/cyto.a.22347  1
2013 Sheppard S, Triulzi C, Ardolino M, Serna D, Zhang L, Raulet DH, Guerra N. Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire. Blood. 121: 5025-33. PMID 23649470 DOI: 10.1182/blood-2012-12-471607  1
2013 van Bergen J, Thompson A, van Pel M, Retière C, Salvatori D, Raulet DH, Trowsdale J, Koning F. HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model. Journal of Immunology (Baltimore, Md. : 1950). 190: 2880-5. PMID 23390293 DOI: 10.4049/jimmunol.1200650  1
2013 Croxford JL, Tang ML, Pan MF, Huang CW, Kamran N, Phua CM, Chng WJ, Ng SB, Raulet DH, Gasser S. ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells. Blood. 121: 2512-21. PMID 23349395 DOI: 10.1182/blood-2012-08-449025  1
2013 Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annual Review of Immunology. 31: 413-41. PMID 23298206 DOI: 10.1146/annurev-immunol-032712-095951  1
2013 Bélanger S, Tu MM, Rahim MMA, Mahmoud AB, Patel R, Tai LH, Troke AD, Wilhelm BT, Landry JR, Zhu Q, Tung KS, Raulet DH, Makrigiannis AP. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice (Blood (2012) 120, 3(592-602)) Blood. 122: 2525. DOI: 10.1182/blood-2013-08-524249  1
2012 Jung H, Hsiung B, Pestal K, Procyk E, Raulet DH. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. The Journal of Experimental Medicine. 209: 2409-22. PMID 23166357 DOI: 10.1084/jem.20120565  1
2012 Coombes JL, Han SJ, van Rooijen N, Raulet DH, Robey EA. Infection-induced regulation of natural killer cells by macrophages and collagen at the lymph node subcapsular sinus. Cell Reports. 2: 124-35. PMID 22840403 DOI: 10.1016/j.celrep.2012.06.001  1
2012 Bélanger S, Tu MM, Rahim MM, Mahmoud AB, Patel R, Tai LH, Troke AD, Wilhelm BT, Landry JR, Zhu Q, Tung KS, Raulet DH, Makrigiannis AP. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. Blood. 120: 592-602. PMID 22661698 DOI: 10.1182/blood-2012-02-408732  1
2012 Wortham BW, Eppert BL, Motz GT, Flury JL, Orozco-Levi M, Hoebe K, Panos RJ, Maxfield M, Glasser SW, Senft AP, Raulet DH, Borchers MT. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease. Journal of Immunology (Baltimore, Md. : 1950). 188: 4468-75. PMID 22467655 DOI: 10.4049/jimmunol.1102643  1
2011 Xia M, Guerra N, Sukhova GK, Yang K, Miller CK, Shi GP, Raulet DH, Xiong N. Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis. Circulation. 124: 2933-43. PMID 22104546 DOI: 10.1161/CIRCULATIONAHA.111.034850  1
2011 Tokuyama M, Lorin C, Delebecque F, Jung H, Raulet DH, Coscoy L. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation. Plos Pathogens. 7: e1002265. PMID 21966273 DOI: 10.1371/journal.ppat.1002265  1
2011 Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science (New York, N.Y.). 331: 44-9. PMID 21212348 DOI: 10.1126/science.1198687  1
2010 Nice TJ, Deng W, Coscoy L, Raulet DH. Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase. Journal of Immunology (Baltimore, Md. : 1950). 185: 5369-76. PMID 20870941 DOI: 10.4049/jimmunol.1000247  1
2010 Fine JH, Chen P, Mesci A, Allan DS, Gasser S, Raulet DH, Carlyle JR. Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition. Cancer Research. 70: 7102-13. PMID 20823164 DOI: 10.1158/0008-5472.CAN-10-1316  1
2010 Joncker NT, Shifrin N, Delebecque F, Raulet DH. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. The Journal of Experimental Medicine. 207: 2065-72. PMID 20819928 DOI: 10.1084/jem.20100570  1
2010 Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. 1990. Journal of Immunology (Baltimore, Md. : 1950). 184: 4587-91. PMID 20410495  1
2010 Blanchard N, Kanaseki T, Escobar H, Delebecque F, Nagarajan NA, Reyes-Vargas E, Crockett DK, Raulet DH, Delgado JC, Shastri N. Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 3033-42. PMID 20173027 DOI: 10.4049/jimmunol.0903712  1
2010 Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. β2-microglobulin deficient mice lack CD4-8+ cytolytic T cells Journal of Immunology. 184: 742-746.  1
2009 Uche UN, Huber CR, Raulet DH, Xiong N. Recombination signal sequence-associated restriction on TCRdelta gene rearrangement affects the development of tissue-specific gammadelta T cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 4931-9. PMID 19801518 DOI: 10.4049/jimmunol.0901859  1
2009 Raulet DH, Guerra N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nature Reviews. Immunology. 9: 568-80. PMID 19629084 DOI: 10.1038/nri2604  1
2009 Raulet DH. Natural killer cells: remembrances of things past. Current Biology : Cb. 19: R294-6. PMID 19368874 DOI: 10.1016/j.cub.2009.02.023  1
2009 Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. Journal of Immunology (Baltimore, Md. : 1950). 182: 4572-80. PMID 19342631 DOI: 10.4049/jimmunol.0803900  1
2009 Whang MI, Guerra N, Raulet DH. Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin. Journal of Immunology (Baltimore, Md. : 1950). 182: 4557-64. PMID 19342629 DOI: 10.4049/jimmunol.0802439  1
2009 Nice TJ, Coscoy L, Raulet DH. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress. The Journal of Experimental Medicine. 206: 287-98. PMID 19171762 DOI: 10.1084/jem.20081335  1
2009 Kawamura T, Takeda K, Kaneda H, Matsumoto H, Hayakawa Y, Raulet DH, Ikarashi Y, Kronenberg M, Yagita H, Kinoshita K, Abo T, Okumura K, Smyth MJ. NKG2A inhibits invariant NKT cell activation in hepatic injury. Journal of Immunology (Baltimore, Md. : 1950). 182: 250-8. PMID 19109156  1
2008 Joncker NT, Raulet DH. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunological Reviews. 224: 85-97. PMID 18759922 DOI: 10.1111/j.1600-065X.2008.00658.x  1
2008 Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Greenberg NR, Raulet DH. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 28: 571-80. PMID 18394936 DOI: 10.1016/j.immuni.2008.02.016  1
2008 Xiong N, Zhang L, Kang C, Raulet DH. Gene placement and competition control T cell receptor gamma variable region gene rearrangement. The Journal of Experimental Medicine. 205: 929-38. PMID 18378791 DOI: 10.1084/jem.20071275  1
2008 Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Raulet DH. NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy (DOI:10.1016/j.immuni.2008.02.016) Immunity. 28: 723. DOI: 10.1016/j.immuni.2008.04.001  1
2007 Coscoy L, Raulet DH. DNA mismanagement leads to immune system oversight. Cell. 131: 836-8. PMID 18045527 DOI: 10.1016/j.cell.2007.11.012  1
2007 Pinto AK, Jamieson AM, Raulet DH, Hill AB. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. Journal of Virology. 81: 12564-71. PMID 17855532 DOI: 10.1128/JVI.01328-07  1
2007 Arina A, Murillo O, Hervás-Stubbs S, Azpilikueta A, Dubrot J, Tirapu I, Huarte E, Alfaro C, Pérez-Gracia JL, González-Aseguinolaza G, Sarobe P, Lasarte JJ, Jamieson A, Prieto J, Raulet DH, et al. The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN gamma. International Journal of Cancer. Journal International Du Cancer. 121: 1282-95. PMID 17520674 DOI: 10.1002/ijc.22795  1
2007 Roth C, Rothlin C, Riou S, Raulet DH, Lemke G. Stromal-cell regulation of natural killer cell differentiation. Journal of Molecular Medicine (Berlin, Germany). 85: 1047-56. PMID 17426948 DOI: 10.1007/s00109-007-0195-0  1
2007 Cavanaugh VJ, Raulet DH, Campbell AE. Upregulation of CD94/NKG2A receptors and Qa-1b ligand during murine cytomegalovirus infection of salivary glands. The Journal of General Virology. 88: 1440-5. PMID 17412971 DOI: 10.1099/vir.0.82444-0  1
2007 Xiong N, Raulet DH. Development and selection of gammadelta T cells. Immunological Reviews. 215: 15-31. PMID 17291276 DOI: 10.1111/j.1600-065X.2006.00478.x  1
2006 Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunological Reviews. 214: 130-42. PMID 17100881 DOI: 10.1111/j.1600-065X.2006.00460.x  1
2006 Gasser S, Raulet D. The DNA damage response, immunity and cancer Seminars in Cancer Biology. 16: 344-347. PMID 16914325 DOI: 10.1016/j.semcancer.2006.07.004  1
2006 Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nature Reviews. Immunology. 6: 520-31. PMID 16799471 DOI: 10.1038/nri1863  1
2006 Caraux A, Lu Q, Fernandez N, Riou S, Di Santo JP, Raulet DH, Lemke G, Roth C. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nature Immunology. 7: 747-54. PMID 16751775 DOI: 10.1038/ni1353  1
2006 Raulet DH. Missing self recognition and self tolerance of natural killer (NK) cells. Seminars in Immunology. 18: 145-50. PMID 16740393 DOI: 10.1016/j.smim.2006.03.003  1
2006 Gasser S, Raulet DH. The DNA damage response arouses the immune system. Cancer Research. 66: 3959-62. PMID 16618710 DOI: 10.1158/0008-5472.CAN-05-4603  1
2006 Chiesa S, Mingueneau M, Fuseri N, Malissen B, Raulet DH, Malissen M, Vivier E, Tomasello E. Multiplicity and plasticity of natural killer cell signaling pathways. Blood. 107: 2364-72. PMID 16291591 DOI: 10.1182/blood-2005-08-3504  1
2005 Orr MT, Edelmann KH, Vieira J, Corey L, Raulet DH, Wilson CB. Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice. Plos Pathogens. 1: e7. PMID 16201019 DOI: 10.1371/journal.ppat.0010007  1
2005 Kawamura H, Yagita H, Nisizawa T, Izumi N, Miyaji C, Vance RE, Raulet DH, Okumura K, Abo T. Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells. European Journal of Immunology. 35: 2358-66. PMID 15997467 DOI: 10.1002/eji.200425933  1
2005 Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 436: 1186-90. PMID 15995699 DOI: 10.1038/nature03884  1
2005 Ota T, Takeda K, Akiba H, Hayakawa Y, Ogasawara K, Ikarashi Y, Miyake S, Wakasugi H, Yamamura T, Kronenberg M, Raulet DH, Kinoshita K, Yagita H, Smyth MJ, Okumura K. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood. 106: 184-92. PMID 15746081 DOI: 10.1182/blood-2004-11-4257  1
2005 Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood. 105: 4416-23. PMID 15728129 DOI: 10.1182/blood-2004-08-3156  1
2004 Bach JF, Bendelac A, Brenner MB, Cantor H, De Libero G, Kronenberg M, Lanier LL, Raulet DH, Shlomchik MJ, von Herrath MG. The role of innate immunity in autoimmunity. The Journal of Experimental Medicine. 200: 1527-31. PMID 15611284 DOI: 10.1084/jem.20042110  1
2004 Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nature Immunology. 5: 996-1002. PMID 15454923 DOI: 10.1038/ni1114  1
2004 Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T, Ebert EC, Green PH, Jabri B. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 21: 357-66. PMID 15357947 DOI: 10.1016/j.immuni.2004.06.020  1
2004 Anfossi N, Robbins SH, Ugolini S, Georgel P, Hoebe K, Bouneaud C, Ronet C, Kaser A, DiCioccio CB, Tomasello E, Blumberg RS, Beutler B, Reiner SL, Alexopoulou L, Lantz O, ... Raulet DH, et al. Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. Journal of Immunology (Baltimore, Md. : 1950). 173: 3773-82. PMID 15356124  1
2004 Xiong N, Kang C, Raulet DH. Positive selection of dendritic epidermal gammadelta T cell precursors in the fetal thymus determines expression of skin-homing receptors. Immunity. 21: 121-31. PMID 15345225 DOI: 10.1016/j.immuni.2004.06.008  1
2004 Gold MC, Munks MW, Wagner M, McMahon CW, Kelly A, Kavanagh DG, Slifka MK, Koszinowski UH, Raulet DH, Hill AB. Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. Journal of Immunology (Baltimore, Md. : 1950). 172: 6944-53. PMID 15153514  1
2004 André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, et al. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. European Journal of Immunology. 34: 961-71. PMID 15048706 DOI: 10.1002/eji.200324705  1
2004 Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proceedings of the National Academy of Sciences of the United States of America. 101: 3527-32. PMID 14990792 DOI: 10.1073/pnas.0308304101  1
2004 Tanamachi DM, Moniot DC, Cado D, Liu SD, Hsia JK, Raulet DH. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. Journal of Immunology (Baltimore, Md. : 1950). 172: 1074-82. PMID 14707081  1
2004 Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. Journal of Immunology (Baltimore, Md. : 1950). 172: 864-70. PMID 14707057  1
2004 Xiong N, Baker JE, Kang C, Raulet DH. The genomic arrangement of T cell receptor variable genes is a determinant of the developmental rearrangement pattern. Proceedings of the National Academy of Sciences of the United States of America. 101: 260-5. PMID 14691262 DOI: 10.1073/pnas.0303738101  1
2003 Anfossi N, Lucas M, Diefenbach A, Bühring HJ, Raulet D, Tomasello E, Vivier E. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line European Journal of Immunology. 33: 3514-3522. PMID 14635062 DOI: 10.1002/eji.200324573  1
2003 Junqueira-Kipnis AP, Kipnis A, Jamieson A, Juarrero MG, Diefenbach A, Raulet DH, Turner J, Orme IM. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. Journal of Immunology (Baltimore, Md. : 1950). 171: 6039-45. PMID 14634116  1
2003 Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nature Reviews. Immunology. 3: 781-90. PMID 14523385 DOI: 10.1038/nri1199  1
2003 Tajima A, Tanaka T, Ebata T, Takeda K, Kawasaki A, Kelly JM, Darcy PK, Vance RE, Raulet DH, Kinoshita K, Okumura K, Smyth MJ, Yagita H. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo. Journal of Immunology (Baltimore, Md. : 1950). 171: 1715-21. PMID 12902470  1
2003 Diefenbach A, Hsia JK, Hsiung MY, Raulet DH. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. European Journal of Immunology. 33: 381-91. PMID 12645935 DOI: 10.1002/immu.200310012  1
2003 Diefenbach A, Raulet DH. Innate immune recognition by stimulatory immunoreceptors. Current Opinion in Immunology. 15: 37-44. PMID 12495731 DOI: 10.1016/S0952-7915(02)00007-9  1
2002 Diefenbach A, Raulet DH. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunological Reviews. 188: 9-21. PMID 12445277 DOI: 10.1034/j.1600-065X.2002.18802.x  1
2002 Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nature Immunology. 3: 1142-9. PMID 12426565 DOI: 10.1038/ni858  1
2002 Hayakawa Y, Kelly JM, Westwood JA, Darcy PK, Diefenbach A, Raulet D, Smyth MJ. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. Journal of Immunology (Baltimore, Md. : 1950). 169: 5377-81. PMID 12421908  1
2002 Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity. 17: 19-29. PMID 12150888 DOI: 10.1016/S1074-7613(02)00333-3  1
2002 McMahon CW, Zajac AJ, Jamieson AM, Corral L, Hammer GE, Ahmed R, Raulet DH. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. Journal of Immunology (Baltimore, Md. : 1950). 169: 1444-52. PMID 12133970  1
2002 Chambers CA, Kang J, Wu Y, Held W, Raulet DH, Allison JP. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor. Blood. 99: 4509-16. PMID 12036882 DOI: 10.1182/blood.V99.12.4509  1
2002 Lian RH, Maeda M, Lohwasser S, Delcommenne M, Nakano T, Vance RE, Raulet DH, Takei F. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. Journal of Immunology (Baltimore, Md. : 1950). 168: 4980-7. PMID 11994449  1
2002 Xiong N, Kang C, Raulet DH. Redundant and unique roles of two enhancer elements in the TCRgamma locus in gene regulation and gammadelta T cell development. Immunity. 16: 453-63. PMID 11911829 DOI: 10.1016/S1074-7613(02)00285-6  1
2002 Fraser KP, Gays F, Robinson JH, van Beneden K, Leclercq G, Vance RE, Raulet DH, Brooks CG. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. European Journal of Immunology. 32: 868-78. PMID 11870631 DOI: 10.1002/1521-4141(200203)32:3<868::AID-IMMU868>3.0.CO;2-A  1
2002 Vance RE, Jamieson AM, Cado D, Raulet DH. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proceedings of the National Academy of Sciences of the United States of America. 99: 868-73. PMID 11782535 DOI: 10.1073/pnas.022500599  1
2001 Hanke T, Takizawa H, Raulet DH. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. European Journal of Immunology. 31: 3370-9. PMID 11745355 DOI: 10.1002/1521-4141(200111)31:11<3370::AID-IMMU3370>3.0.CO;2-2  1
2001 Voehringer D, Blaser C, Brawand P, Raulet DH, Hanke T, Pircher H. Viral infections induce abundant numbers of senescent CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 167: 4838-43. PMID 11673487  1
2001 Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413: 165-71. PMID 11557981 DOI: 10.1038/35093109  1
2001 Diefenbach A, Raulet DH. Strategies for target cell recognition by natural killer cells. Immunological Reviews. 181: 170-84. PMID 11513138 DOI: 10.1034/j.1600-065X.2001.1810114.x  1
2001 McMahon CW, Raulet DH. Expression and function of NK cell receptors in CD8+ T cells. Current Opinion in Immunology. 13: 465-70. PMID 11498303 DOI: 10.1016/S0952-7915(00)00242-9  1
2001 Kang J, Volkmann A, Raulet DH. Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling. The Journal of Experimental Medicine. 193: 689-98. PMID 11257136 DOI: 10.1084/jem.193.6.689  1
2001 Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annual Review of Immunology. 19: 291-330. PMID 11244039 DOI: 10.1146/annurev.immunol.19.1.291  1
2001 Hanke T, Raulet DH. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. Journal of Immunology (Baltimore, Md. : 1950). 166: 3002-7. PMID 11207249  1
2001 Tanamachi DM, Hanke T, Takizawa H, Jamieson AM, Raulet DH. Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules Journal of Experimental Medicine. 193: 307-315. PMID 11157051 DOI: 10.1084/jem.193.3.307  1
2001 Raulet DH, Melchers F. Lymphocyte development: Editorial overview Current Opinion in Immunology. 13: 163-165. DOI: 10.1016/S0952-7915(00)00199-0  1
2000 Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunology. 1: 119-26. PMID 11248803 DOI: 10.1038/77793  1
2000 Kraft JR, Vance RE, Pohl J, Martin AM, Raulet DH, Jensen PE. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. The Journal of Experimental Medicine. 192: 613-24. PMID 10974028 DOI: 10.1084/jem.192.5.613  1
2000 Roth C, Carlyle JR, Takizawa H, Raulet DH. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity. 13: 143-53. PMID 10933402  1
2000 Held W, Lowin-Kropf B, Raulet DH. Generation of short-term murine natural killer cell clones to analyze Ly49 gene expression. Methods in Molecular Biology (Clifton, N.J.). 121: 5-12. PMID 10818712 DOI: 10.1385/1-59259-044-6:5  1
2000 Corral L, Hanke T, Vance RE, Cado D, Raulet DH. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. European Journal of Immunology. 30: 920-30. PMID 10741410 DOI: 10.1002/1521-4141(200003)30:3<920::AID-IMMU920>3.0.CO;2-P  1
2000 Coles MC, Raulet DH. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. Journal of Immunology (Baltimore, Md. : 1950). 164: 2412-8. PMID 10679077  1
2000 Coles MC, McMahon CW, Takizawa H, Raulet DH. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. European Journal of Immunology. 30: 236-44. PMID 10602046 DOI: 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO;2-X  1
2000 Schaller RD, Roth C, Raulet DH, Saykally RJ. Near-field second harmonic imaging of granular membrane structures in natural killer cells Journal of Physical Chemistry B. 104: 5217-5220.  1
1999 Vance RE, Jamieson AM, Raulet DH. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. The Journal of Experimental Medicine. 190: 1801-12. PMID 10601355 DOI: 10.1084/jem.190.12.1801  1
1999 Diefenbach A, Raulet DH. Natural killer cells: stress out, turn on, tune in. Current Biology : Cb. 9: R851-3. PMID 10574749  1
1999 Corral L, Takizawa H, Hanke T, Jamieson AM, Raulet DH. A new monoclonal antibody reactive with several Ly49 NK cell receptors mediates redirected lysis of target cells. Hybridoma. 18: 359-66. PMID 10571266  1
1999 Zajac AJ, Vance RE, Held W, Sourdive DJ, Altman JD, Raulet DH, Ahmed R. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. Journal of Immunology (Baltimore, Md. : 1950). 163: 5526-34. PMID 10553080  1
1999 Kang J, Coles M, Raulet DH. Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. The Journal of Experimental Medicine. 190: 973-82. PMID 10510087 DOI: 10.1084/jem.190.7.973  1
1999 Zerrahn J, Volkmann A, Coles MC, Held W, Lemonnier FA, Raulet DH. Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proceedings of the National Academy of Sciences of the United States of America. 96: 11470-5. PMID 10500200 DOI: 10.1073/pnas.96.20.11470  1
1999 Baker JE, Kang J, Xiong N, Chen T, Cado D, Raulet DH. A novel element upstream of the Vgamma2 gene in the murine T cell receptor gamma locus cooperates with the 3' enhancer to act as a locus control region. The Journal of Experimental Medicine. 190: 669-79. PMID 10477551 DOI: 10.1084/jem.190.5.669  1
1999 Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, Miller JD, Altman JD, Liu Y, Cado D, Lemonnier FA, Bjorkman PJ, Raulet DH. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity. 11: 67-77. PMID 10435580 DOI: 10.1016/S1074-7613(00)80082-5  1
1999 Raulet DH. Development and tolerance of natural killer cells. Current Opinion in Immunology. 11: 129-34. PMID 10322148 DOI: 10.1016/S0952-7915(99)80023-5  1
1999 Raulet DH. Does a low level of expression of HLA molecules engender autoimmunity? The New England Journal of Medicine. 340: 314-5. PMID 9920960 DOI: 10.1056/NEJM199901283400413  1
1998 Hanke T, Corral L, Vance RE, Raulet DH. 2F1 antigen, the mouse homolog of the rat "mast cell function-associated antigen", is a lectin-like type II transmembrane receptor expressed by natural killer cells. European Journal of Immunology. 28: 4409-17. PMID 9862378 DOI: 10.1002/(SICI)1521-4141(199812)28:12<4409::AID-IMMU4409>3.0.CO;2-3  1
1998 Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). The Journal of Experimental Medicine. 188: 1841-8. PMID 9815261 DOI: 10.1084/jem.188.10.1841  1
1998 Baker JE, Cado D, Raulet DH. Developmentally programmed rearrangement of T cell receptor Vgamma genes is controlled by sequences immediately upstream of the Vgamma genes. Immunity. 9: 159-68. PMID 9729036  1
1998 Kang J, Fehling HJ, Laplace C, Malissen M, Cado D, Raulet DH. T cell receptor gamma gene regulatory sequences prevent the function of a novel TCRgamma/pTalpha pre-T cell receptor. Immunity. 8: 713-21. PMID 9655485 DOI: 10.1016/S1074-7613(00)80576-2  1
1998 Kang J, Coles M, Cado D, Raulet DH. The developmental fate of T cells is critically influenced by TCRgammadelta expression. Immunity. 8: 427-38. PMID 9586633 DOI: 10.1016/S1074-7613(00)80548-8  1
1998 Vance RE, Raulet DH. Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells. Current Topics in Microbiology and Immunology. 230: 135-60. PMID 9586355  1
1998 Dorfman JR, Raulet DH. Acquisition of Ly49 receptor expression by developing natural killer cells. The Journal of Experimental Medicine. 187: 609-18. PMID 9463411 DOI: 10.1084/jem.187.4.609  1
1997 Dorfman JR, Zerrahn J, Coles MC, Raulet DH. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice. Journal of Immunology (Baltimore, Md. : 1950). 159: 5219-25. PMID 9548460  1
1997 Vance RE, Tanamachi DM, Hanke T, Raulet DH. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. European Journal of Immunology. 27: 3236-41. PMID 9464811 DOI: 10.1002/eji.1830271222  1
1997 Held W, Raulet DH. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. European Journal of Immunology. 27: 2876-84. PMID 9394813 DOI: 10.1002/eji.1830271120  1
1997 Kang J, Raulet DH. Events that regulate differentiation of alpha beta TCR+ and gamma delta TCR+ T cells from a common precursor. Seminars in Immunology. 9: 171-9. PMID 9200328 DOI: 10.1006/smim.1997.0069  1
1997 Held W, Raulet DH. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. The Journal of Experimental Medicine. 185: 2079-88. PMID 9182679 DOI: 10.1084/jem.185.12.2079  1
1997 Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunological Reviews. 155: 41-52. PMID 9059881 DOI: 10.1111/j.1600-065X.1997.tb00938.x  1
1997 Zerrahn J, Held W, Raulet DH. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell. 88: 627-36. PMID 9054502 DOI: 10.1016/S0092-8674(00)81905-4  1
1997 Wu MF, Raulet DH. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. Journal of Immunology (Baltimore, Md. : 1950). 158: 1628-33. PMID 9029098  1
1997 Zerrahn J, Held W, Coles M, Raulet DH. Positive selection of TCR-transgenic CD8+ T cells directed by hematopoietic cells Immunobiology. 197: 144-145.  1
1996 Held W, Cado D, Raulet DH. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. The Journal of Experimental Medicine. 184: 2037-41. PMID 8920892  1
1996 Held W, Dorfman JR, Wu MF, Raulet DH. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. European Journal of Immunology. 26: 2286-92. PMID 8898935 DOI: 10.1002/eji.1830261003  1
1996 Raulet DH. Recognition events that inhibit and activate natural killer cells. Current Opinion in Immunology. 8: 372-7. PMID 8793997 DOI: 10.1016/S0952-7915(96)80127-0  1
1996 Dorfman JR, Raulet DH. Major histocompatibility complex genes determine natural killer cell tolerance. European Journal of Immunology. 26: 151-5. PMID 8566058 DOI: 10.1002/eji.1830260123  1
1996 Dorfrnan JR, Held W, Wu MF, Raulet DH. Functional and phenotypic evidence for MHC mediated control of the natural killer (NK) cell repertoire Faseb Journal. 10: A1158.  1
1996 Held W, Dorfmann JR, Wu MF, Raulet DH. Correction: Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire European Journal of Immunology. 26: 3242.  1
1995 Hsiang YH, Goldman JP, Raulet DH. The role of c-Myb or a related factor in regulating the T cell receptor gamma gene enhancer. Journal of Immunology (Baltimore, Md. : 1950). 154: 5195-204. PMID 7730626  1
1995 Raulet DH, Held W. Natural killer cell receptors: the offs and ons of NK cell recognition. Cell. 82: 697-700. PMID 7671299 DOI: 10.1016/0092-8674(95)90466-2  1
1995 Held W, Roland J, Raulet DH. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature. 376: 355-8. PMID 7630404 DOI: 10.1038/376355a0  1
1995 Kang J, Baker J, Raulet DH. Evidence that productive rearrangements of TCR gamma genes influence the commitment of progenitor cells to differentiate into alpha beta or gamma delta T cells. European Journal of Immunology. 25: 2706-9. PMID 7589149 DOI: 10.1002/eji.1830250946  1
1995 Zhang Y, Cado D, Asarnow DM, Komori T, Alt FW, Raulet DH, Allison JP. The role of short homology repeats and TdT in generation of the invariant gamma delta antigen receptor repertoire in the fetal thymus. Immunity. 3: 439-47. PMID 7584135 DOI: 10.1016/1074-7613(95)90173-6  1
1995 Raulet DH, Correa I, Corral L, Dorfman J, Wu MF. Inhibitory effects of class I molecules on murine NK cells: speculations on function, specificity and self-tolerance. Seminars in Immunology. 7: 103-7. PMID 7579192 DOI: 10.1006/smim.1995.0014  1
1995 Correa I, Raulet DH. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity. 2: 61-71. PMID 7541307 DOI: 10.1016/1074-7613(95)90079-9  1
1994 Raulet DH. MHC class I-deficient mice Advances in Immunology. 55: 381-421. PMID 8304235  1
1994 Correa I, Corral L, Raulet DH. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. European Journal of Immunology. 24: 1323-31. PMID 8206092 DOI: 10.1002/eji.1830240613  1
1994 Coles MC, Raulet DH. Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes. The Journal of Experimental Medicine. 180: 395-9. PMID 8006596 DOI: 10.1084/jem.180.1.395  1
1994 Holsti MA, McArthur J, Allison JP, Raulet DH. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody Journal of Immunology. 152: 1618-1628. PMID 7907103  1
1994 Raulet DH. T-Cell Immunity: How γδ T cells make a living Current Biology. 4: 246-248. PMID 7857396 DOI: 10.1016/S0960-9822(00)00055-5  1
1993 Hsiang YHH, Spencer D, Wang S, Speck NA, Raulet DH. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-γ and -δ gene expression Journal of Immunology. 150: 3905-3916. PMID 8473739  1
1993 Asarnow DM, Cado D, Raulet DH. Selection is not required to produce invariant T-cell receptor γ-gene junctional sequences Nature. 362: 158-160. PMID 8383806 DOI: 10.1038/362158a0  1
1993 Goldman JP, Spencer DM, Raulet DH. Ordered rearrangement of variable region genes of the T cell receptor γ locus correlates with transcription of the unrearranged genes Journal of Experimental Medicine. 177: 729-739. PMID 8382255  1
1993 McArthur JG, Raulet DH. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4 Journal of Experimental Medicine. 178: 1645-1653. PMID 8228811 DOI: 10.1084/jem.178.5.1645  1
1992 Raulet DH. A sense of something missing Nature. 358: 21-22. PMID 1614524 DOI: 10.1038/358021a0  1
1992 Raulet DH, Liao NS, Correa I, Bix M. Lymphocyte development in mice deficient for MHC Class I expression Advances in Experimental Medicine and Biology. 323: 67-72. PMID 1362478  1
1992 Liao NS, Raulet DH. Expression of the Mls-1a superantigen results in an increased frequency of Vβ14+ T cells Journal of Immunology. 149: 1151-1155. PMID 1323609  1
1992 Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones Nature. 356: 607-609. PMID 1313950  1
1991 Spencer DM, Hsiang YH, Goldman JP, Raulet DH. Identification of a T-cell-specific transcriptional enhancer located 3′ of Cγ1 in the murine T-cell receptor γ locus Proceedings of the National Academy of Sciences of the United States of America. 88: 800-804. PMID 1992471  1
1991 Raulet DH, Spencer DM, Hsiang YH, Goldman JP, Bix M, Liao NS, Zulstra M, Jaenisch R, Correa I. Control of γδ T-cell development Immunological Reviews. 184-204. PMID 1650759  1
1990 Wilson JM, Danos O, Grossman M, Raulet DH, Mulligan RC. Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 87: 439-43. PMID 2296599  1
1990 Allison JP, Raulet DH. The immunobiology of γδ+ T cells Seminars in Immunology. 2: 59-65. PMID 2151798  1
1990 Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. β2-microglobulin deficient mice lack CD4- 8+ cytolytic T cells Nature. 344: 742-746. PMID 2139497  1
1990 Miescher GC, Liao NS, Lees RK, MacDonald HR, Raulet DH. Selective expression of Vδ6 genes by B2A2- CD4- CD8- T cell receptor γ/δ thymocytes European Journal of Immunology. 20: 41-45. PMID 2137782  1
1990 Liao NS, Maltzman J, Raulet DH. Expression of the Vβ5.1 gene by murine peripheral T cells is controlled by MHC genes and skewed to the CD8+ subset Journal of Immunology. 144: 844-848. PMID 1967275  1
1989 Korman AJ, Maruyama J, Raulet DH. Rearrangement by inversion of a T-cell receptor delta variable region gene located 3' of the delta constant region gene. Proceedings of the National Academy of Sciences of the United States of America. 86: 267-71. PMID 2789518  1
1989 Raulet DH. Antigens for γ/δ T cells Nature. 339: 342-343. PMID 2786146  1
1989 Raulet DH. The structure, function, and molecular genetics of the γ/δ T cell receptor Annual Review of Immunology. 7: 175-207. PMID 2653369  1
1989 Holsti MA, Raulet DH. IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells Journal of Immunology. 143: 2514-2519. PMID 2571638  1
1989 Marusic-Galesic S, Saito T, Tentori L, Zuniga-Pflucker J, Raulet DH, Allison JP, Kruisbeek AM. A novel γδ T cell receptor for antigen adds limited diversity to the γδ repertoire in adult thymus Journal of Immunology. 142: 28-34. PMID 2521236  1
1989 Liao NS, Maltzman J, Raulet DH. Positive selection determines T cell receptor Vβ14 gene usage by CD8+ T cells Journal of Experimental Medicine. 170: 135-143. PMID 2501444  1
1988 MacDonald HR, Howe RC, Pedrazzini T, Lees RK, Budd RC, Schneider R, Liao NS, Zinkernagel RM, Louis JA, Raulet DH. T-cell lineages, repertoire selection and tolerance induction Immunological Reviews. 104: 157-182. PMID 3049315  1
1988 Korman AJ, Marusic-Galesic S, Spencer D, Kruisbeek AM, Raulet DH. Predominant variable region gene usage by gamma/delta T cell receptor-bearing cells in the adult thymus. The Journal of Experimental Medicine. 168: 1021-40. PMID 2971752  1
1987 Garman RD, Raulet DH. Characterization of a novel murine T cell-activating factor Journal of Immunology. 138: 1121-1129. PMID 3543122  1
1987 Garman RD, Jacobs KA, Clark SC, Raulet DH. B-cell-stimulatory factor 2 (β2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells Proceedings of the National Academy of Sciences of the United States of America. 84: 7629-7633. PMID 3499611  1
1987 Raulet DH. Tolerance, and more Cell. 49: 153-154. PMID 3494519  1
1987 Lieberman J, Raulet DH. T cell gamma receptor Immunologic Research. 6: 288-293. PMID 3323346 DOI: 10.1007/BF02935523  1
1986 Garman RD, Ko JL, Vulpe CD, Raulet DH. T-cell receptor variable region gene usage in T-cell populations Proceedings of the National Academy of Sciences of the United States of America. 83: 3987-3991. PMID 3487085  1
1986 Garman RD, Doherty PJ, Raulet DH. Diversity, rearrangement, and expression of murine T cell gamma genes Cell. 45: 733-742. PMID 3486721 DOI: 10.1016/0092-8674(86)90787-7  1
1986 Lieberman J, Verret CR, Kranz DM, Hubbard SC, Saito H, Raulet DH, Tonegawa S, Eisen HN. A phosphorylated, disulfide-linked membrane protein in murine cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 83: 7870-4. PMID 2945206 DOI: 10.1073/pnas.83.20.7870  1
1986 Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells Cell. 45: 917-927. PMID 2871944 DOI: 10.1016/0092-8674(86)90566-0  1
1985 Raulet DH. Expression and function of interleukin-2 receptors on immature thymocytes Nature. 314: 101-103. PMID 3919309  1
1985 Raulet DH, Garman RD, Saito H, Tonegawa S. Developmental regulation of T-cell receptor gene expression. Nature. 314: 103-7. PMID 2983227 DOI: 10.1038/314103a0  1
1982 Raulet DH, Bevan MJ. A differentiation factor required for the expression of cytotoxic T-cell function Nature. 296: 754-757. PMID 6803172 DOI: 10.1038/296754a0  1
1982 Raulet DH, Hunig T, Parker DC. T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants Journal of Immunology. 128: 908-912. PMID 6798126  1
1982 Raulet DH, Bevan MJ. Helper T cells for cytotoxic T lymphocytes need not be I region restricted Journal of Experimental Medicine. 155: 1766-1784. PMID 6176668  1
1982 Klein JR, Raulet DH, Pasternack MS, Bevan MJ. Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen Journal of Experimental Medicine. 155: 1198-1203. PMID 6174673  1
1980 Raulet DH, Gottlieb PD, Bevan MJ. Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1 Journal of Immunology. 125: 1136-1143. PMID 6447723  1
1979 Marshak-Rothstein A, Fink P, Gridley T, Raulet DH, Bevan MJ, Gefter ML. Properties and applications of monoclonal antibodies directed against determinants of the THY-1 locus Journal of Immunology. 122: 2491-2497. PMID 87465  1
Show low-probability matches.